Collaboration - December 20, 2016
Orion starts strategic collaboration
The Wisconsin Technology Innovation Initiative (Wi2) and Orion Corporation have announced a strategic collaboration in pursuit of new medicines for oncological diseases. Under the terms of the agreement, target proteins (modes of action) identified and initially validated at UW-Madison will be provided to Orion as a first step in establishing a research and development collaboration. […]
Collaboration - December 16, 2016
AstraZeneca, Lilly to develop treatment for Alzheimer’s
AstraZeneca and Eli Lilly and Company have signed a worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42 (Aβ42), which is currently in Phase I trials as a potential disease-modifying treatment for Alzheimer’s disease (AD). This agreement builds on the existing collaboration related to AZD3293, a BACE inhibitor in two pivotal Phase III […]
Collaboration - December 6, 2016
Round table discussion on cross-border cancer research
Last thursday, over 20 healthcare stakeholders, experts and politicians gather in Stockholm for a round table discussion on increasing collaboration on cross-border cancer research and innovation between Sweden and the United States, in order to improve patient outcomes. The roundtable was hosted by the U.S. Ambassador Azita Raji and the Swedish Minister for Higher Education and […]
CDMO - December 5, 2016
Recipharm enters new collaboration
Recipharm is entering into a collaboration with Laccure AB for the commercial manufacture and delivery of Laccure Pessary. The new product, which has been developed to help women suffering from bacterial vaginosis, will be manufactured, packaged and distributed globally from Recipharm’s facility in Karlskoga that specialises in the production of semi-solid products. Over the past […]
Collaboration - December 5, 2016
Nuevolution receives research grant and enters collaboration
Nuevolution has received a three-year grant from Innovation Fund Denmark together with professor Kristian Helin, Biotech Research and Innovation Center (BRIC) at University of Copenhagen, to pursue discovery and development of therapeutics directed towards specific cancer types. The three-year project has a budget of DKK 24.4 million (SEK 32.2 million) and Innovation Fund Denmark contributes […]
Biotech Business - November 9, 2016
Symcel, TiKa Diagnostics and St. George’s University of London form partnership
Symcel has partnered with TiKa Diagnostics and St. George’s University of London, for the use of its microcalorimetry technology in testing mycobacteria and for antimicrobial peptide (AMP) studies. The project between Symcel and TiKa Diagnostics, a spin-out from St. George’s University of London, has the potential to enable rapid Mtb culture confirmation, reducing detection time […]
